California Department of Public Health Report issue

Contributed to NME Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2012
NCT01502306
First Marketed Drug
2003
botulism immune globulin (BabyBIG)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

California Department of Public Health